S&P 500   3,322.70 (-0.21%)
DOW   29,268.61 (-0.27%)
QQQ   223.34 (-0.02%)
AAPL   317.87 (-0.27%)
FB   220.49 (-0.74%)
MSFT   167.66 (+0.34%)
GOOGL   1,475.94 (-0.24%)
AMZN   1,871.26 (+0.35%)
CGC   24.57 (-1.29%)
NVDA   248.41 (-0.35%)
MU   58.45 (+1.37%)
GE   11.70 (-1.02%)
ACB   2.06 (-3.29%)
F   9.11 (-0.55%)
NFLX   337.60 (-0.61%)
BAC   34.36 (-1.01%)
GILD   62.50 (-0.76%)
DIS   143.19 (-0.79%)
S&P 500   3,322.70 (-0.21%)
DOW   29,268.61 (-0.27%)
QQQ   223.34 (-0.02%)
AAPL   317.87 (-0.27%)
FB   220.49 (-0.74%)
MSFT   167.66 (+0.34%)
GOOGL   1,475.94 (-0.24%)
AMZN   1,871.26 (+0.35%)
CGC   24.57 (-1.29%)
NVDA   248.41 (-0.35%)
MU   58.45 (+1.37%)
GE   11.70 (-1.02%)
ACB   2.06 (-3.29%)
F   9.11 (-0.55%)
NFLX   337.60 (-0.61%)
BAC   34.36 (-1.01%)
GILD   62.50 (-0.76%)
DIS   143.19 (-0.79%)
S&P 500   3,322.70 (-0.21%)
DOW   29,268.61 (-0.27%)
QQQ   223.34 (-0.02%)
AAPL   317.87 (-0.27%)
FB   220.49 (-0.74%)
MSFT   167.66 (+0.34%)
GOOGL   1,475.94 (-0.24%)
AMZN   1,871.26 (+0.35%)
CGC   24.57 (-1.29%)
NVDA   248.41 (-0.35%)
MU   58.45 (+1.37%)
GE   11.70 (-1.02%)
ACB   2.06 (-3.29%)
F   9.11 (-0.55%)
NFLX   337.60 (-0.61%)
BAC   34.36 (-1.01%)
GILD   62.50 (-0.76%)
DIS   143.19 (-0.79%)
S&P 500   3,322.70 (-0.21%)
DOW   29,268.61 (-0.27%)
QQQ   223.34 (-0.02%)
AAPL   317.87 (-0.27%)
FB   220.49 (-0.74%)
MSFT   167.66 (+0.34%)
GOOGL   1,475.94 (-0.24%)
AMZN   1,871.26 (+0.35%)
CGC   24.57 (-1.29%)
NVDA   248.41 (-0.35%)
MU   58.45 (+1.37%)
GE   11.70 (-1.02%)
ACB   2.06 (-3.29%)
F   9.11 (-0.55%)
NFLX   337.60 (-0.61%)
BAC   34.36 (-1.01%)
GILD   62.50 (-0.76%)
DIS   143.19 (-0.79%)
Log in
(Ad)
Learn how to make more money in 24 hours than most folks make all year long...This could be the easiest way to turn $5,000 into $196,868.

NASDAQ:CGEN - Compugen Stock Price, Forecast & News

$6.17
+0.05 (+0.82 %)
(As of 01/21/2020 11:14 AM ET)
Today's Range
$6.12
Now: $6.17
$6.33
50-Day Range
$5.34
MA: $5.85
$6.20
52-Week Range
$2.73
Now: $6.17
$6.45
Volume12,025 shs
Average Volume251,933 shs
Market Capitalization$316.46 million
P/E RatioN/A
Dividend YieldN/A
Beta2.74
Compugen Ltd., a therapeutic discovery company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel and Europe. The company's therapeutic pipeline consists of immuno-oncology programs against novel drug targets in the areas of unmet medical needs in various cancer types and patient populations. Read More…

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:CGEN
CUSIPN/A
Phone972-3765-8585

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$17.80 million
Book Value$0.73 per share

Profitability

Net Income$-22,600,000.00

Miscellaneous

Employees89
Market Cap$316.46 million
Next Earnings Date2/25/2020 (Estimated)
OptionableOptionable

Receive CGEN News and Ratings via Email

Sign-up to receive the latest news and ratings for CGEN and its competitors with MarketBeat's FREE daily newsletter.


(Ad)


What if you could buy one tiny stock today for $10 - at the center of a growing tech industry - that experts believe will explode a massive 77,400%?

Wall Street legend Paul Mampilly recently identified this as the stock of the century.

Buying up a handful of shares of this small company now could change your life and even make you millions.

Compugen (NASDAQ:CGEN) Frequently Asked Questions

What is Compugen's stock symbol?

Compugen trades on the NASDAQ under the ticker symbol "CGEN."

How were Compugen's earnings last quarter?

Compugen Ltd. (NASDAQ:CGEN) posted its earnings results on Monday, November, 11th. The biotechnology company reported ($0.10) earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.11) by $0.01. View Compugen's Earnings History.

When is Compugen's next earnings date?

Compugen is scheduled to release their next quarterly earnings announcement on Tuesday, February 25th 2020. View Earnings Estimates for Compugen.

What price target have analysts set for CGEN?

2 equities research analysts have issued 12-month target prices for Compugen's stock. Their forecasts range from $9.00 to $10.00. On average, they anticipate Compugen's share price to reach $9.50 in the next twelve months. This suggests a possible upside of 54.0% from the stock's current price. View Analyst Price Targets for Compugen.

What is the consensus analysts' recommendation for Compugen?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Compugen in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Compugen.

Has Compugen been receiving favorable news coverage?

Media coverage about CGEN stock has been trending extremely negative recently, InfoTrie Sentiment reports. The research firm identifies positive and negative news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Compugen earned a news sentiment score of -4.0 on InfoTrie's scale. They also assigned news stories about the biotechnology company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for Compugen.

Who are some of Compugen's key competitors?

What other stocks do shareholders of Compugen own?

Who are Compugen's key executives?

Compugen's management team includes the folowing people:
  • Dr. Anat Cohen-Dayag, CEO, Pres & Director (Age 52)
  • Mr. Ari Krashin, Chief Financial & Operating Officer (Age 46)
  • Dr. John J. Hunter Ph.D., Chief Scientific Officer (Age 56)
  • Mr. Kirk A. Christoffersen, Sr. VP of Corp. & Bus. Devel. (Age 50)
  • Dr. Zurit Levine, Sr. VP of Technology Innovation (Age 51)

How do I buy shares of Compugen?

Shares of CGEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Compugen's stock price today?

One share of CGEN stock can currently be purchased for approximately $6.17.

How big of a company is Compugen?

Compugen has a market capitalization of $316.46 million and generates $17.80 million in revenue each year. The biotechnology company earns $-22,600,000.00 in net income (profit) each year or ($0.41) on an earnings per share basis. Compugen employs 89 workers across the globe.View Additional Information About Compugen.

What is Compugen's official website?

The official website for Compugen is http://www.cgen.com/.

How can I contact Compugen?

Compugen's mailing address is AZRIELI CENTER 26 HAROKMIM STREET BUILDING D, HOLON L3, 5885849. The biotechnology company can be reached via phone at 972-3765-8585 or via email at [email protected]


MarketBeat Community Rating for Compugen (NASDAQ CGEN)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  253 (Vote Outperform)
Underperform Votes:  237 (Vote Underperform)
Total Votes:  490
MarketBeat's community ratings are surveys of what our community members think about Compugen and other stocks. Vote "Outperform" if you believe CGEN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CGEN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel